These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch. Stefana B; Ray DW; Melmed S Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12502-6. PubMed ID: 8901611 [TBL] [Abstract][Full Text] [Related]
7. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion. Shimon I; Yan X; Ray DW; Melmed S J Clin Invest; 1997 Jul; 100(2):357-63. PubMed ID: 9218512 [TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor as an intrapituitary mediator of ACTH secretion. Schwartz J; Ray DW; Perez FM Neuroendocrinology; 1999 Jan; 69(1):34-43. PubMed ID: 9892849 [TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis. Auernhammer CJ; Chesnokova V; Melmed S Endocrinology; 1998 May; 139(5):2201-8. PubMed ID: 9564823 [TBL] [Abstract][Full Text] [Related]
10. Effects of oncostatin M on hormone release of rat pituitary cells in primary culture. Kim DS; Choi HS; Park YS; Kim TW J Korean Med Sci; 2000 Jun; 15(3):323-6. PubMed ID: 10895976 [TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF. Li QL; Yano H; Ren SG; Li X; Friedman TC; Melmed S Endocrine; 1997 Dec; 7(3):325-30. PubMed ID: 9657069 [TBL] [Abstract][Full Text] [Related]
12. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. Bousquet C; Ray DW; Melmed S J Biol Chem; 1997 Apr; 272(16):10551-7. PubMed ID: 9099700 [TBL] [Abstract][Full Text] [Related]